Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Psoma

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Personalized Medicine|April 28, 2023
Surgical Management of Groove Pancreatitis: A Case ReportAristeidis Ioannidis, Alexandra Menni, Georgios Tzikos, et al.
Anticancer Research|February 5, 2020
Genetic Variations of <i>VEGFA</i> Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal CarcinomaElizabeth Psoma, Georgia-Angeliki Koliou, Foteinos-Ioannis Dimitrakopoulos, et al.
British Journal of Cancer|June 4, 2020
Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes-a Hellenic Cooperative Oncology Group (HeCOG) TrialAngelos Koutras, Flora Zagouri, Georgia-Angeliki Koliou, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Personalized Medicine|April 28, 2023
Surgical Management of Groove Pancreatitis: A Case ReportAristeidis Ioannidis, Alexandra Menni, Georgios Tzikos, et al.
Anticancer Research|February 5, 2020
Genetic Variations of <i>VEGFA</i> Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal CarcinomaElizabeth Psoma, Georgia-Angeliki Koliou, Foteinos-Ioannis Dimitrakopoulos, et al.
British Journal of Cancer|June 4, 2020
Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes-a Hellenic Cooperative Oncology Group (HeCOG) TrialAngelos Koutras, Flora Zagouri, Georgia-Angeliki Koliou, et al.
Pageof 2